-
Mashup Score: 476The SMHP™ position statement on therapeutic carbohydrate reduction for type 1 diabetes - 24 day(s) ago
This article presents the position of the Society of Metabolic Health Practitioners (SMHP) regarding therapeutic carbohydrate reduction (TCR) nutrition interventions for type 1 diabetes mellitus (T1DM). A modified Delphi methodology was used to arrive at a consensus consisting of several focus groups, multiple rounds, and an anonymous survey. The field of endocrinology has seen many new advances for the treatment of T1DM including hybrid closed-loop insulin delivery systems and continuous glucose monitors for better glycaemic control, monoclonal antibodies to delay the onset of disease and increased access to paediatric endocrinologists, among many other noteworthy achievements. Despite these advancements, standard of care approaches to T1DM result in higher than acceptable morbidity and mortality, with a high prevalence of microvascular and macrovascular complications. Insulin resistance in type 1 diabetes is an independent risk factor for adverse outcomes even in well controlled type
Source: journalofmetabolichealth.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 435Carbohydrate reduction for metabolic disease is distinct from the ketogenic diet for epilepsy - 8 month(s) ago
Recent reviews of using therapeutic carbohydrate reduction to treat metabolic disease in paediatric patients have consistently made errors in the form of bias against recommending this nutrient-dense eating pattern despite strong evidence for its use in adults and emerging evidence in paediatric patients. The purpose of this perspective is to review these errors, which include conflating 4:1 ketogenic diets with well-formulated ketogenic diets and the needless medicalisation of using therapeutic carbohydrate reduction in paediatric populations.
Source: journalofmetabolichealth.orgCategories: General Medicine News, General HCPsTweet-
Please share this article with your Pediatrician and the @AmerAcadPeds https://t.co/7ZkDBOPCOV Children with obesity deserve a trial of a well-formulated ketogenic diet Before taking Ozempic or undergoing Bariatric Surgery!
-
-
Mashup Score: 435Carbohydrate reduction for metabolic disease is distinct from the ketogenic diet for epilepsy - 8 month(s) ago
Recent reviews of using therapeutic carbohydrate reduction to treat metabolic disease in paediatric patients have consistently made errors in the form of bias against recommending this nutrient-dense eating pattern despite strong evidence for its use in adults and emerging evidence in paediatric patients. The purpose of this perspective is to review these errors, which include conflating 4:1 ketogenic diets with well-formulated ketogenic diets and the needless medicalisation of using therapeutic carbohydrate reduction in paediatric populations.
Source: journalofmetabolichealth.orgCategories: General Medicine News, General HCPsTweet-
Please share this article with your Pediatrician and the @AmerAcadPeds https://t.co/7ZkDBOPCOV Children with obesity deserve a trial of a well-formulated ketogenic diet Before taking Ozempic or undergoing Bariatric Surgery!
-
🚨New consensus statement for people with T1 diabetes. A very low-carbohydrate diet is an evidence-based way to maintain a healthy A1c. While reducing dependence on medication. Important for patients and practitioners! @TheSMHP @DoctorTro @drericwestman 👏 https://t.co/hNBhFJpuv9 https://t.co/0OuXz8PB0B